Immunobiology of hepatitis B virus infection. (Q41694097)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25331910%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

title

Immunobiology of hepatitis B virus infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25331910%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25331910%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

2

Yasuhito Tanaka

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25331910%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

26 November 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25331910%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25331910%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25331910%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

179-189

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25331910%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25331910%20AND%20SRC:MED&resulttype=core&format=json

Hepatitis B virus infection--natural history and clinical consequences

21 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Genomic analysis of the host response to hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

The size of the viral inoculum contributes to the outcome of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Outcome of Hepatitis B Virus Infection in Homosexual Men and Its Relation to Prior Human Immunodeficiency Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Natural history of chronic hepatitis B in co-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Oscillating CD8(+) T cell effector functions after antigen recognition in the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

CD40 activation rescues antiviral CD8⁺ T cells from PD-1-mediated exhaustion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Immune tolerance split between hepatitis B virus precore and core proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Antiviral actions of interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Stealth and cunning: hepatitis B and hepatitis C viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Nonlinear partial differential equations and applications: Genomic analysis of the host response to hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Hepatitis B virus biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Temporal analysis of early immune responses in patients with acute hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Natural killer cells are characterized by the concomitantly increased interferon-γ and cytotoxicity in acute resolved hepatitis B patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Compromised function of natural killer cells in acute and chronic viral hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Natural killer T cell activation inhibits hepatitis B virus replication in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Early kinetics of innate and adaptive immune responses during hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Hepatitis B virus immunopathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Reactivation of hepatitis B virus following rituximab-plus-steroid combination chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Cooperation between CD4+ and CD8+ T cells: when, where, and how.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Peroxidase-anti-peroxidase detection of hepatitis B surface and core antigen in liver biopsy specimens from patients with chronic type B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Inhibition of hepatitis B virus replication by interferon requires proteasome activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Signal transduction pathways that inhibit hepatitis B virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Immunobiology and pathogenesis of viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Hepatic T cells and liver tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Antigen-presenting cell function in the tolerogenic liver environment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Expression of the interleukin-7 receptor alpha chain (CD127) on virus-specific CD8+ T cells identifies functionally and phenotypically defined memory T cells during acute resolving hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Does maternal antibody to core antigen prevent recognition of transplacental transmission of hepatitis-B-virus infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

A transgenic mouse model of the chronic hepatitis B surface antigen carrier state

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Clinical relevance of mutations in the precore genome of the hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

X-deficient woodchuck hepatitis virus mutants behave like attenuated viruses and induce protective immunity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Inhibition of cellular proteasome activities enhances hepadnavirus replication in an HBX-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Liver-primed CD8+ T cells suppress antiviral adaptive immunity through galectin-9-independent T-cell immunoglobulin and mucin 3 engagement of high-mobility group box 1 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

The molecular basis of the failed immune response in chronic HBV: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

γδT cells drive myeloid-derived suppressor cell-mediated CD8+ T cell exhaustion in hepatitis B virus-induced immunotolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Selection of chronic hepatitis B therapy with high barrier to resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Treating cancer with genetically engineered T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

A practical approach to immunotherapy of hepatocellular carcinoma using T cells redirected against hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

From TCR Engagement to T Cell Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12439

21 January 2018

Identifiers

DOI

10.1111/HEPR.12439

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25331910%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25331910%20AND%20SRC:MED&resulttype=core&format=json